Research on the Effects of the Chronic Treatment With Different Doses of Urocortin 2 in Heart Failure Rats
Corticotropin-releasing factor (CRF) receptor type 2 (CRF 2 ) exists in both cardiomyocytes and neurocytes. The purpose of this research was to explore if chronic treatment with urocortin 2 (UCN2), a CRF 2 receptor agonist, at different doses can improve prognosis and regulate the expression of CRF...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
SAGE Publishing,
2019-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|